Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis.

Valiyeva E, Herrmann N, Rochon PA, Gill SS, Anderson GM.

CMAJ. 2008 Aug 26;179(5):438-46. doi: 10.1503/cmaj.071540.

2.

Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.

Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J.

CMAJ. 2008 Apr 8;178(8):1005-11. doi: 10.1503/cmaj.071265. Erratum in: CMAJ. 2008 May 20;178(11):1466.

3.

Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Kamble P, Chen H, Sherer JT, Aparasu RR.

Drugs Aging. 2009;26(6):483-92. doi: 10.2165/00002512-200926060-00005.

PMID:
19591523
4.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
5.

Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.

Moisan J, Grégoire JP.

Clin Ther. 2010;32 Suppl 1:S21-31. doi: 10.1016/j.clinthera.2010.01.003.

PMID:
20152549
6.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
7.

How much are atypical antipsychotic agents being used, and do they reach the populations who need them? A Canadian experience.

Dewa CS, Remington G, Herrmann N, Fearnley J, Goering P.

Clin Ther. 2002 Sep;24(9):1466-76.

PMID:
12380638
8.

Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from Italian Medicines Agency. Results from the EPIFARM-Elderly Project.

Franchi C, Tettamanti M, Marengoni A, Bonometti F, Pasina L, Cortesi L, Fortino I, Bortolotti A, Merlino L, Lucca U, Riva E, Nobili A.

Eur Neuropsychopharmacol. 2012 Aug;22(8):569-77. doi: 10.1016/j.euroneuro.2011.12.009. Epub 2012 Jan 31.

PMID:
22297160
9.

Trends in use of antipsychotics in elderly patients with dementia: Impact of national safety warnings.

Gallini A, Andrieu S, Donohue JM, Oumouhou N, Lapeyre-Mestre M, Gardette V.

Eur Neuropsychopharmacol. 2014 Jan;24(1):95-104. doi: 10.1016/j.euroneuro.2013.09.003. Epub 2013 Sep 17.

10.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
11.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
12.

Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances.

Schulze J, van den Bussche H, Glaeske G, Kaduszkiewicz H, Wiese B, Hoffmann F.

Eur Neuropsychopharmacol. 2013 Sep;23(9):1034-42. doi: 10.1016/j.euroneuro.2013.02.001. Epub 2013 Mar 15.

PMID:
23498307
13.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].

Saravane D, Feve B, Frances Y, Corruble E, Lancon C, Chanson P, Maison P, Terra JL, Azorin JM; avec le soutien institutionnel du laboratoire Lilly.

Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. French.

PMID:
19748369
14.

The effect of antidepressant warnings on prescribing trends in Ontario, Canada.

Kurdyak PA, Juurlink DN, Mamdani MM.

Am J Public Health. 2007 Apr;97(4):750-4. Epub 2007 Feb 28.

15.

Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia.

Trifirò G, Sini G, Sturkenboom MC, Vanacore N, Mazzaglia G, Caputi AP, Cricelli C, Brignoli O, Aguglia E, Biggio G, Samani F.

Int Clin Psychopharmacol. 2010 Jan;25(1):22-8. doi: 10.1097/YIC.0b013e3283334f08.

PMID:
19898244
16.

Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.

Weinbrenner S, Assion HJ, Stargardt T, Busse R, Juckel G, Gericke CA.

Pharmacopsychiatry. 2009 Mar;42(2):66-71. doi: 10.1055/s-0028-1103293. Epub 2009 Mar 23.

PMID:
19308881
17.

Antipsychotic prescribing in older people.

Neil W, Curran S, Wattis J.

Age Ageing. 2003 Sep;32(5):475-83. Review.

18.

Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.

Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):412-20.

PMID:
16287199
19.

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.

Morrato EH, Druss B, Hartung DM, Valuck RJ, Allen R, Campagna E, Newcomer JW.

Arch Gen Psychiatry. 2010 Jan;67(1):17-24. doi: 10.1001/archgenpsychiatry.2009.179.

PMID:
20048219
20.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk